Oura to acquire Counsel Health for $625 million, placing a big bet on AI care
Oura Health is acquiring Counsel Health for $625 million, aiming to integrate AI and wearable data into clinical care. The deal follows a partnership where Counsel's AI chatbot was added to Oura's app. Oura reported $533 million in revenue for Q3 and $1.75 billion for fiscal 2026, up 92% YoY. Both companies plan to continue their direct-to-consumer and enterprise services post-acquisition.
How this was made

The 30-second read
Why it matters
The deal expands Oura's move from consumer data to reimbursable clinical care, creating a new revenue stream but also raising integration and regulatory questions.
Market read
First‑report of a sizable private‑company acquisition in the digital‑health space; may influence valuations of similar startups.
What to watch
potential conflict of interest with Eli Lilly's minority stake in Oura
Background
Oura, a maker of smart rings, announced a $625 million acquisition of private telehealth firm Counsel Health to embed AI‑driven clinical services.
Market effects
could spur further M&A activity in digital health and AI‑enabled wearables
may boost investor interest in Nordic health‑tech startups
limited to health‑tech and AI sectors
Counterpoint
integration risk and regulatory scrutiny could outweigh synergies
Key entities
- CompanyOura
Finnish wearable‑tech firm acquiring Counsel Health
- CompanyCounsel Health
Boston‑based telehealth provider with AI chatbot


